← Holders
Patient Square Capital LP
What Patient Square Capital LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1819257 · Filed Nov 10, 2026
- Positions
- 23
- Reported value
- $626.7M
- Opened
- 6
- Closed
- 6
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$373.9M24 positions
- Dec 31, 2025$467.1M28 positions
- Mar 31, 2026$563.6M29 positions
- Jun 30, 2026$645.5M23 positions
- Sep 30, 2026$626.7M23 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
ROIVRoivant Sciences Ltd. | 7.7M | −3.9% | $282M | 45% |
RVMDRevolution Medicines, Inc. | 196K | −29.0% | $40.2M | 6.4% |
UTHRUnited Therapeutics Corp | 62.7K | +68.8% | $34M | 5.4% |
ARGXArgenx SE | 28K | +21.7% | $26.8M | 4.3% |
PHVSPharvaris N.V. | 808.6K | +20.5% | $25.7M | 4.1% |
ABVXAbivax S.A. | 243K | +17.7% | $24.1M | 3.8% |
BLTEBelite Bio, Inc | 131.7K | +19.7% | $22.4M | 3.6% |
MIRMMirum Pharmaceuticals, Inc. | 234K | −10.2% | $20M | 3.2% |
ZLABZai Lab Ltd | 591.5K | New | $15.6M | 2.5% |
DFTXDefinium Therapeutics, Inc. | 385K | New | $14.7M | 2.3% |
CMPSCOMPASS Pathways plc | 1.1M | New | $13.1M | 2.1% |
DBVTDBV Technologies S.A. | 1.1M | +21.6% | $13M | 2.1% |
ONCBeOne Medicines Ltd. | 33.5K | −62.8% | $12.3M | 2% |
COGTCogent Biosciences, Inc. | 361.9K | −14.8% | $11.6M | 1.8% |
RCUSArcus Biosciences, Inc. | 410K | +15.2% | $10.6M | 1.7% |
BNTXBioNTech SE | 105.4K | −21.6% | $10.4M | 1.7% |
ELVNEnliven Therapeutics, Inc. | 212.5K | ±0% | $9.7M | 1.6% |
PCVXVaxcyte, Inc. | 166K | New | $9.4M | 1.5% |
KYMRKymera Therapeutics, Inc. | 84K | +76.8% | $9.4M | 1.5% |
ALLOAllogene Therapeutics, Inc. | 4.6M | −9.9% | $7.3M | 1.2% |
ZNTLZentalis Pharmaceuticals, Inc. | 2M | New | $5.6M | 0.9% |
IVAInventiva S.A. | 1.2M | −37.9% | $4.5M | 0.7% |
HROWHarrow, Inc. | 145K | New | $4.5M | 0.7% |